Despite a new report this week drawing attention to the risk of T1DE, a number of pilot services for people with type 1 diabetes and eating disorders in England are at risk of closure as national ...

Try adding a finely chopped red pepper along with the leeks and mushrooms. Add some chopped chives or fresh basil for extra flavour. 'At risk' groups such as infants, children, pregnant women, the ...

We welcome new guidance from the National Institute of Health and Care Excellence (NICE) that mark an important shift in the treatment of type 2 diabetes.

Causes of type 1 diabetes It’s normal to wonder if something you’ve done could have caused your type 1 diabetes – or a child’s type 1 diabetes. But there’s nothing you could have done to prevent it.

Devastating diabetes complications costs the UK healthcare system £6.2 billion a year, which highlights not just the seriousness of diabetes but also the importance of getting the right care to people ...

We're going to explore whether an intermittent fasting diet can help you put your type 2 diabetes into remission. What are intermitten ...

The first ever immunotherapy for type 1 diabetes has been licensed for use in the UK. The Medicines and Healthcare products Regulatory Agency (MHRA) has decided teplizumab, also known as Tzield, is ...

We take a look at some of the exciting diabetes research developments announced in January 2026, and what the findings could mean for people living with or affected by diabetes.

In some areas of the UK, there are type 2 diabetes remission programmes available through the NHS and health boards. Not every area has a specific type 2 remission programme available, and where there ...

Our new analysis predicts that, without significant government action, up to 5.5m people in the UK could be living with diabetes by 2030.

Our analysis has revealed that the number of children receiving treatment for type 2 diabetes in Paediatric Diabetes Units in England and Wales has increased by over 50%. We’re calling on the ...

Update, 14 August 2025: The Medicines and Healthcare products Regulatory Agency (MHRA) has licensed teplizumab as the first-ever immunotherapy for type 1 diabetes in the UK. Read our news story to ...